Unione Europea - lituano - EMA (European Medicines Agency)

biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vakcinos - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. naudoti šios vakcinos turėtų būti laikantis oficialių rekomendacijų.

Unione Europea - lituano - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - eprinomectin, esafoxolaner, praziquantel - eprinomectin, combinations, , avermectins, antiparasitic products, insecticides and repellents - katės - for cats with, or at risk from mixed infections by cestodes, nematodes and ectoparasites. veterinarinis vaistas yra tik nurodyta, kada visi trys grupes tuo pačiu metu.

Unione Europea - lituano - EMA (European Medicines Agency)

amarin pharmaceuticals ireland limited - icosapent ethyl - dislipidemijos - lipidą keičiančios medžiagos - indicated to reduce cardiovascular risk as an adjunct to statin therapy.

Unione Europea - lituano - EMA (European Medicines Agency)

pfizer europe ma eeig - nirmatrelvir, ritonavir - covid-19 virus infection - paxlovid is indicated for the treatment of coronavirus disease 2019 (covid-19) in adults who do not require supplemental oxygen and who are at increased risk for progressing to severe covid 19.

Unione Europea - lituano - EMA (European Medicines Agency)

laboratorios lesvi s.l. - dimetilfumaratas - išsėtinė sklerozė, grįžtamoji-pervedimo - imunosupresantai - dimethyl fumarate neuraxpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Lituania - lituano - SMCA (Valstybinė vaistų kontrolės tarnyba)

krka d.d., novo mesto (slovėnija) - tabletės - vienoje tabletėje yra: febantelio- 150 mg, pirantelio embonato - 144 mg, prazikvantelio- 50 mg. - Šunims dehelmintizuoti, esant mišriai nematodų ir kaspinuočių invazijai.

Lituania - lituano - SMCA (Valstybinė vaistų kontrolės tarnyba)

chanelle pharmaceuticals manufacturing limited (airija) - tabletės - vienoje tabletėje yra: prazikvantelio - 50 mg, pirantelio - 50 mg (atitinka 144 mg pirantelio embonato), febantelio - 150 mg. - Šunims gydyti, esant mišrioms nematodų ir cestodų infekcijoms.

Lituania - lituano - SMCA (Valstybinė vaistų kontrolės tarnyba)

ceva sante animale, libourne (prancūzija) - tabletės - vienoje tabletėje yra: febantelio - 150 mg, pirantelio (embonato) - 50 mg, prazikvantelio - 50 mg. - suaugusiems šunims ir šuniukams, užsikrėtusiems cestodais ir nematodais, gydyti.

Lituania - lituano - SMCA (Valstybinė vaistų kontrolės tarnyba)

ceva sante animale, libourne (prancūzija) - tabletės - vienoje tabletėje yra: febantelio - 525 mg, pirantelio (embonato) - 175 mg, prazikvantelio - 175 mg. - daugiau kaip 17,5 kg sveriantiems šunims, užsikrėtusiems cestodais ir nematodais, gydyti.

Lituania - lituano - SMCA (Valstybinė vaistų kontrolės tarnyba)

chanelle pharmaceuticals manufacturing limited (airija) - tabletės - vienoje tabletėje yra: prazikvantelio - 50 mg, pirantelio - 50 mg (atitinka 144 mg pirantelio embonato), febantelio - 150 mg. - Šunims gydyti, esant mišrioms nematodų ir cestodų infekcijoms.